Skip to main content
Renew your Professional Membership before the June 30, 2025 deadline.
Renew Today!
  • Get Involved
  • Jobs & Career Resources
  • Tools & Resources
American Heart Association - Professional Heart Daily
  • |
  • Login
Become a Member
  • Communities
  • Guidelines & Statements
  • Journals
  • Meetings
  • Education
  • Members / Councils
  • Research Programs
Become a Member
  1. Home
  2. Guidelines & Statements
  3. Hub

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia


Newspaper Chart icon on shiny red circle button.

Science News

Science News Summary

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients with Supraventricular Tachycardia

Commentary

Optimal SVT management Are we there

Top Things to Know

Top Things to Know: Guideline for the Management of Adult Patients with Supraventricular Tachycardia

Chart Icon on Shiny Red Circle Button

Slide Sets

AHAACC Guideline Slide Set

2015 Supraventricular Tachycardia Guideline Slide Set (PDF)

Document folder icon on shiny red circle button.

Journal Resources

Executive Summary

Executive Summary: 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia

Toolbox icon on shiny red circle button.

Apps and Tools

Guidelines On The Go Mobile App

For Android

For iOS

Computer and Health icon on shiny red circle button.

Guideline Central

Management of Adult Patients With Supraventricular Tachycardia

Newspaper icon on shiny red circle button.

News

Science News

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients with Supraventricular Tachycardia

phd_gl_hub_recommended_reading

Recommended Reading

2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease - Full Text

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

2013 ACCF AHA Guideline for the Management of Heart Failure

2011 ACCF AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

  • 1-888-242-2453 (Inside U.S.)
  • 1-214-570-5935 (Outside U.S.)
  • Website Inquiries
  • 1-888-242-2453 (Inside U.S.)
  • 1-972-349-5803 (Outside U.S.)
  • [email protected]
  • About PHD
  • Advertising
  • Frequently Asked Questions (FAQs)
American Heart Association

National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service
1-800-AHA-USA-1
1-800-242-8721
Contact Us
Hours
Monday - Friday: 7 a.m. - 9 p.m. CT
Saturday: 9 a.m. - 5 p.m. CT
Closed on Sundays

About Us

  • About the AHA/ASA
  • Annual Report
  • AHA Financial Information
  • Careers
  • International Programs
  • Latest Science News
  • AHA/ASA Media Newsroom

Get Involved

  • Donate
  • Advocate
  • Volunteer
  • ShopHeart
  • ShopCPR

Our Sites

  • American Heart Association
  • American Stroke Association
  • CPR & ECC
  • Go Red For Women
  • More Sites
  • X formerly known as Twitter
  • YouTube
  • Facebook
  • Instagram
  • Tik Tok
  • LinkedIn
  • Pinterest
  • National Health Council Standards of Excellence Certification Program page for Standards of Excellence
  • Better Business Bureau page for American Heart Association
  • Charity Navigator Home
  • Secured by Sectigo page for SSL certificates
  • AHA Careers
  • Privacy Policy
  • Medical Advice Disclaimer
  • Accessibility Statement
  • Copyright Policy
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Whistleblower Policy
  • Content Editorial Guidelines
  • Suppliers & Providers
  • State Fundraising Notices


©2025 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.
The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress ™ DHHS, Go Red ™ AHA ; National Wear Red Day® is a registered trademark.

×
American Heart Association

This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.

Proceed